Activity value 71malaysia Buyer,Last transaction date:
2025-11-21
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for g pharma global (m) sdn bhd from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 14 transactions, with a transaction quantity of 565 and a transaction weight of 0.
YearTransactionsQuantityWeight
20242750
2025145650
Bill of lading data
<
1/15
>
Trade date
2025/11/21
B/L No.
——
Suppliers
genex pharma
Buyers
g pharma global (m) sdn bhd
5genex pharma
indiasupplier,they trade on 2025-11-21
15.26%
>
+View All
Products
Total 19
ProductsTransactionsPerDetail
mitotan 233.33%>
sp 500 233.33%>
e tablet 233.33%>
bat 233.33%>
capsule 116.67%>
+View All
Hscode rank
Total 5
HSCode NameTransactionsPerDetail
HS 30049099350%>
HS 30049049233.33%>
HS 30049079116.67%>
Trading Area
Total 2
AreaTransactionsPerDetail
india1789.47%>
vietnam210.53%>
Port statistics
Total 2
Port NameTransactionsPerDetail
kuala lumpur - int'l1263.16%>
kuala lumpur315.79%>
g pharma global (m) sdn bhd is malaysia Buyer,
and primarily engages in the import and export business of products such as mitotan,sp 500,e tablet.
According to the 52wmb.com global trade database, as of 2025-11-21, the company has completed 19 international trades,
with its main trading regions covering india,vietnam etc.
The core products include HS30049099,HS30049049,HS30049079 etc,
often transported via kuala lumpur - int'l,port kuala lumpur etc,
and its main trading partners are regalia life science pvt ltd.,therdose pharma pvt ltd.,meone healthcare private limited.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on g pharma global (m) sdn bhd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.